India Coronavirus Vaccination
- All
- News
- Videos
- Photos
- Web Stories
-
Covaxin Has Excellent Safety Record: Bharat Biotech On Study Citing Risks
The study, led by Banaras Hindu University (BHU), claimed that Covaxin raised the rare risk of stroke, and Guillain-Barre syndrome, among others.
-
A New All-In-One Vaccine May Prove Effective Against All Coronaviruses
A team of scientists from the world's leading universities have developed a new all-in-one vaccine that they hope can protect humans against a broad range of coronaviruses, including ones that are yet to emerge.
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
Found No Proof Of Covid Vaccine Causing Sudden Death, Says Top Medical Body
Indian researchers found no evidence that COVID-19 vaccination was behind "unexplained sudden deaths", a medical organisation said on Tuesday, instead pointing to the disease itself, binge drinking and intense exercise as risk factors.
-
Days After CoWIN Data Leak Reports, Arrest In Bihar
The Delhi Police have made an arrest in Bihar in connection with the alleged leak of data in the CoWIN portal -- the country's Covid-19 vaccination tracking platform. The man was arrested by the Delhi Police Special Cell's IFFSO (Intelligence Fusion
-
92 Fresh Covid Cases In India, Lowest In Nearly 4 Months
India has recorded 92 fresh coronavirus infections while the active cases have decreased to 2,350, according to Union health ministry data updated on Monday.
-
India Reports 3,962 Covid Cases In 24 Hours, 6% More Than Yesterday
India has logged 3,962 new coronavirus infections, while the active cases have decreased to 36,244 from 40,177, according to the Union Health Ministry data updated on Thursday.
-
India Records 3,720 Covid Cases In 24 Hours, Positivity Rate 2.47%
India has recorded 3,720 new COVID-19 infections and the count of active cases of the disease in the country stands at 40,177, according to Union Health Ministry data updated on Wednesday.
-
Odisha Requests Centre For 50,000 Vaccines Amid Covid Spike
With more than 100 cases of coronavirus being reported in Odisha for four days now, the state government Tuesday requested the Centre for at least an additional 50,000 doses of vaccine.
-
Jharkhand Seeks 50,000 Covid Vaccine Doses From Centre As Cases Rise
Amid rising cases of coronavirus, Jharkhand Health Minister Banna Gupta urged the Centre to provide at least 50,000 COVID-19 vaccine doses to continue with the immunisation drive in the state.
-
No Need For 4th Dose Of Covid Vaccine Given Current Evidence: Expert
Dr Raman Gangakhedkar, former head of epidemiology and communicable diseases at the Indian Council of Medical Research, has discounted the need for the fourth dose of COVID-19 vaccine given the current evidence about the coronavirus and its variants.
-
World's 1st Nasal Vaccine Out On Republic Day: All You Need To Know
iNCOVACC, the world's first COVID-19 intranasal vaccine, will be launched on January 26. The intranasal coronavirus vaccine has been developed by India's Bharat Biotech.
-
Serum Institute Seeks Inclusion Of Covid Jab 'Covovax' In CoWIN Portal
Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine Covovax in the CoWIN portal as a heterologous booster dose for adults, official sources said on Wednesday.
-
Centre's Panel Recommends Market Clearance To Covovax As Covid Booster: Report
An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for adults, Press Trust of India reported.
-
Up To 70% Of Those Under 19 Globally Susceptible To Covid: Study
Fifty to 70 per cent "children" below 19 years globally were susceptible to the SARS-CoV-2 infection by the end of 2021 and before the Omicron wave, showing a need for more effective vaccines and better vaccination coverage, according to a study.
-
Covaxin Has Excellent Safety Record: Bharat Biotech On Study Citing Risks
The study, led by Banaras Hindu University (BHU), claimed that Covaxin raised the rare risk of stroke, and Guillain-Barre syndrome, among others.
-
A New All-In-One Vaccine May Prove Effective Against All Coronaviruses
A team of scientists from the world's leading universities have developed a new all-in-one vaccine that they hope can protect humans against a broad range of coronaviruses, including ones that are yet to emerge.
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
Found No Proof Of Covid Vaccine Causing Sudden Death, Says Top Medical Body
Indian researchers found no evidence that COVID-19 vaccination was behind "unexplained sudden deaths", a medical organisation said on Tuesday, instead pointing to the disease itself, binge drinking and intense exercise as risk factors.
-
Days After CoWIN Data Leak Reports, Arrest In Bihar
The Delhi Police have made an arrest in Bihar in connection with the alleged leak of data in the CoWIN portal -- the country's Covid-19 vaccination tracking platform. The man was arrested by the Delhi Police Special Cell's IFFSO (Intelligence Fusion
-
92 Fresh Covid Cases In India, Lowest In Nearly 4 Months
India has recorded 92 fresh coronavirus infections while the active cases have decreased to 2,350, according to Union health ministry data updated on Monday.
-
India Reports 3,962 Covid Cases In 24 Hours, 6% More Than Yesterday
India has logged 3,962 new coronavirus infections, while the active cases have decreased to 36,244 from 40,177, according to the Union Health Ministry data updated on Thursday.
-
India Records 3,720 Covid Cases In 24 Hours, Positivity Rate 2.47%
India has recorded 3,720 new COVID-19 infections and the count of active cases of the disease in the country stands at 40,177, according to Union Health Ministry data updated on Wednesday.
-
Odisha Requests Centre For 50,000 Vaccines Amid Covid Spike
With more than 100 cases of coronavirus being reported in Odisha for four days now, the state government Tuesday requested the Centre for at least an additional 50,000 doses of vaccine.
-
Jharkhand Seeks 50,000 Covid Vaccine Doses From Centre As Cases Rise
Amid rising cases of coronavirus, Jharkhand Health Minister Banna Gupta urged the Centre to provide at least 50,000 COVID-19 vaccine doses to continue with the immunisation drive in the state.
-
No Need For 4th Dose Of Covid Vaccine Given Current Evidence: Expert
Dr Raman Gangakhedkar, former head of epidemiology and communicable diseases at the Indian Council of Medical Research, has discounted the need for the fourth dose of COVID-19 vaccine given the current evidence about the coronavirus and its variants.
-
World's 1st Nasal Vaccine Out On Republic Day: All You Need To Know
iNCOVACC, the world's first COVID-19 intranasal vaccine, will be launched on January 26. The intranasal coronavirus vaccine has been developed by India's Bharat Biotech.
-
Serum Institute Seeks Inclusion Of Covid Jab 'Covovax' In CoWIN Portal
Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine Covovax in the CoWIN portal as a heterologous booster dose for adults, official sources said on Wednesday.
-
Centre's Panel Recommends Market Clearance To Covovax As Covid Booster: Report
An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for adults, Press Trust of India reported.
-
Up To 70% Of Those Under 19 Globally Susceptible To Covid: Study
Fifty to 70 per cent "children" below 19 years globally were susceptible to the SARS-CoV-2 infection by the end of 2021 and before the Omicron wave, showing a need for more effective vaccines and better vaccination coverage, according to a study.
